沙加斯病治療的全球市場-按分銷渠道（醫院藥店、零售藥店）：行業分析/趨勢/前景/機會分析（2022-2028）

南美錐蟲病是一種熱帶寄生蟲病，在拉丁美洲的 21 個國家廣泛傳播。南美錐蟲病在拉丁美洲流行，但近年來，由於拉丁美洲人向其他國家遷移，全球發病率有所增加。目前，只有苯硝唑和硝夫替莫這兩種藥物可用於治療南美錐蟲病。

本報告分析了沙加斯病治療的全球市場，包括市場的基本結構、促進和抑制市場的因素、按產品類型、分銷渠道和地區劃分的市場趨勢以及主要公司的概況。我們正在調查策略。

目錄

第1章分析目標/先決條件

第二章市場概述

• 分析總結
  • 市場定義和範圍
• 執行摘要
• COM（連貫機會圖）

第三章市場動態、法規及趨勢分析

• 市場動態
  • 市場促進因素
  • 市場製約因素
  • 市場機會
• 需要診斷
• 診斷方法
• 最近的產品批准/發布
• 管道分析
• 監管場景
• PEST 分析
• 流行病學

第 4 章全球南美錐蟲病治療市場：按產品類型（單位：100 萬美元，2017-2028）

• 簡介
• 市場份額：按產品類型（%，2022/2028）
• 同比增長率（YoY）：按產品類型（2017-2028）
• 細分趨勢
  • 苯硝唑
  • 硝夫莫司
    • 簡介
    • 市場規模及預測，同比增長率（YoY）（單位：100萬美元，2017-2028）

第 5 章全球南美錐蟲病治療市場：按分銷渠道（單位：100 萬美元，2017-2028）

• 簡介
• 市場份額：按分銷渠道（%，2022/2028）
• 同比增長率（YoY）：按分銷渠道（2017-2028）
• 細分趨勢
  • 醫院
  • 零售藥店
  • 網上藥店

第 6 章全球南美錐蟲病治療市場：按地區劃分（單位：100 萬美元，2017-2028）

• 簡介
• 市場份額：按地區劃分（%，2022/2028）
• 同比增長率（YoY）：分地區（2017-2028）
• 北美
  • 簡介
  • 市場規模及預測：按產品類型（單位：100 萬美元，2017-2028）
  • 市場規模及預測：按分銷渠道劃分（單位：100 萬美元，2017-2028 年）
  • 市場規模及預測：按國家分類（單位：100 萬美元，2017-2028）
  • 美國
  • 加拿大
• 歐洲
  • 簡介
  • 英國
  • 德國
  • 意大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 日本
  • 澳大利亞
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 玻利維亞
  • 哥倫比亞
  • 委內瑞拉
  • 巴拉圭
  • 其他拉丁美洲國家

第7章競爭態勢

• 熱圖分析
• 公司簡介
  • Nortec Quimica SA
    • 公司簡介
    • 產品組合
    • 主要趨勢
    • 財務表現
  • Bayer AG
  • Laboratorio Elea Phoenix SA
  • Maprimed S.A.
  • Laboratorio Farmaceutico de Pernambuco S/A

第8章 附錄

Chagas disease is a tropical parasitic disease and is endemic in 21 countries in Latin America. Chagas disease can transmitted through blood transfusion, organ transplantation, as well as congenital and oral transmissions. Chagas disease is endemic to Latin America, however, in the recent past, there is a rise in global incidence of Chagas disease due to the migration of Latin American people to other countries. According to data published by World Health Organization (WHO), in February 2018, globally, around 6 Mn to 7 Mn people were infected with Trypansosoma cruzi, the parasite which causes Chagas disease. Benznidazole and Nifurtimox are only two drugs available for the treatment of Chagas disease.

Market Dynamics

Rising migration of people from endemic countries to developed economies such as the U.S. and in countries in Europe is expected to drive growth of Chagas disease treatment market. For instance, according to the data published by Public Library of Science (PLOS), in 2012, there are around 1,62,095 Bolivian adults living in Spain, in which about 97,215 are women (60%) and 64,880 are men. It was estimated that out of total immigrants from Bolivia to Spain 34,202 were found to be potentially infected with Chagas disease. Furthermore, increasing R&D activities for the development of novel treatment methods for Chagas disease is also expected to create a lucrative environment for the market growth. For instance, in 2021, researchers from Saint Louis University Center for Vaccine Development were working on developing a vaccine for Chagas disease. Scientists found Th17 cells, a special type of white blood cell that recognizes the presence of a foreign invader and helps other cells in the immune system to attack and protects the body against Trypanosoma cruzi parasite.

Key features of the study:

• This report provides in-depth analysis of Chagas disease treatment market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global Chagas disease treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Nortec Quimica SA, Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A., and Laboratorio Farmaceutico de Pernambuco S/A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Chagas disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Chagas disease treatment market

Detailed Segmentation:

• Global Chagas Disease Treatment Market, By Product Type:
  • Benznidazole
  • Nifurtimox
• Global Chagas Disease Treatment Market, By Distribution Channel:
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
• Global Chagas Disease Treatment Market, By Geography:
  • North America
    • By Product Type:
    • Benznidazole
    • Nifurtimox
    • By Distribution Channel
    • Hospitals
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • U.S.
    • Canada
  • Europe
    • By Product Type:
    • Benznidazole
    • Nifurtimox
    • By Distribution Channel
    • Hospitals
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Product Type:
    • Benznidazole
    • Nifurtimox
    • By Distribution Channel
    • Hospitals
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • Japan
    • Australia
  • Latin America
    • By Product Type:
    • Benznidazole
    • Nifurtimox
    • By Distribution Channel
    • Hospitals
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Bolivia
    • Columbia
    • Venezuela
    • Paraguay
    • Rest of Latin America
• Company Profiles
  • Nortec Quimica SA*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
  • Bayer AG
  • Laboratorio Elea Phoenix SA
  • Maprimed S.A.
  • Laboratorio Farmaceutico de Pernambuco S/A

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Product Type
• Market Snippet, By Distribution Channel
• Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Diagnosis Needs
• Diagnosis Methods
• Recent Product Approval/Launch
• Pipeline Analysis
• Regulatory Scenario
• PEST Analysis
• Epidemiology

4. Global Chagas Disease Treatment Market, By Product Type, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
• Benznidazole
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Nifurtimox
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Chagas Disease Treatment Market, By Distribution Channel, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
• Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Chagas Disease Treatment Market, By Region, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, By Region, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
• Introduction
• Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
• U.S.
• Canada
• Europe
• Introduction
• Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
• Japan
• Australia
• Latin America
• Introduction
• Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
• Brazil
• Mexico
• Argentina
• Bolivia
• Columbia
• Venezuela
• Paraguay
• Rest of Latin America

7. Competitive Landscape

• Heat Map Analysis
• Company Profiles
• Nortec Quimica SA
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Bayer AG
• Company Overview
• Product Portfolio
• Key Developments
• Strategies
• Laboratorio Elea Phoenix SA
• Company Overview
• Product Portfolio
• Key Developments
• Strategies
• Maprimed S.A.
• Company Overview
• Product Portfolio
• Manufacturing Capabilities
• Laboratorio Farmaceutico de Pernambuco S/A
• Company Overview
• Product Portfolio
• Strategies

8. Section

• Research Methodology
• About us and Sales Contact